American Century Companies’s Ultragenyx Pharmaceutical RARE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$366K Buy
+10,054
New +$366K ﹤0.01% 2611
2022
Q2
Sell
-3,048
Closed -$221K 2375
2022
Q1
$221K Buy
3,048
+90
+3% +$6.53K ﹤0.01% 2161
2021
Q4
$249K Buy
2,958
+229
+8% +$19.3K ﹤0.01% 2143
2021
Q3
$246K Sell
2,729
-6,005
-69% -$541K ﹤0.01% 2141
2021
Q2
$833K Sell
8,734
-135,156
-94% -$12.9M ﹤0.01% 1640
2021
Q1
$16.4M Sell
143,890
-6,715
-4% -$765K 0.01% 681
2020
Q4
$20.8M Sell
150,605
-3,176
-2% -$440K 0.02% 600
2020
Q3
$12.6M Sell
153,781
-17,906
-10% -$1.47M 0.01% 659
2020
Q2
$13.4M Buy
171,687
+61,158
+55% +$4.78M 0.01% 604
2020
Q1
$4.91M Buy
110,529
+2,618
+2% +$116K 0.01% 729
2019
Q4
$4.61M Buy
107,911
+42,069
+64% +$1.8M ﹤0.01% 814
2019
Q3
$2.82M Buy
65,842
+2,947
+5% +$126K ﹤0.01% 916
2019
Q2
$3.99M Buy
62,895
+8,980
+17% +$570K ﹤0.01% 881
2019
Q1
$3.74M Sell
53,915
-4,238
-7% -$294K ﹤0.01% 876
2018
Q4
$2.53M Buy
58,153
+2,588
+5% +$113K ﹤0.01% 933
2018
Q3
$4.24M Sell
55,565
-410
-0.7% -$31.3K ﹤0.01% 893
2018
Q2
$4.3M Buy
55,975
+19,255
+52% +$1.48M ﹤0.01% 882
2018
Q1
$1.87M Buy
36,720
+997
+3% +$50.8K ﹤0.01% 1010
2017
Q4
$1.66M Buy
35,723
+5,752
+19% +$267K ﹤0.01% 1037
2017
Q3
$1.6M Sell
29,971
-633
-2% -$33.7K ﹤0.01% 1072
2017
Q2
$1.9M Sell
30,604
-3,839
-11% -$238K ﹤0.01% 1045
2017
Q1
$2.34M Sell
34,443
-146
-0.4% -$9.9K ﹤0.01% 1018
2016
Q4
$2.43M Sell
34,589
-7,670
-18% -$539K ﹤0.01% 1005
2016
Q3
$3M Buy
42,259
+693
+2% +$49.2K ﹤0.01% 996
2016
Q2
$2.03M Buy
41,566
+3,874
+10% +$189K ﹤0.01% 1024
2016
Q1
$2.39M Sell
37,692
-1,464
-4% -$92.7K ﹤0.01% 966
2015
Q4
$4.39M Buy
39,156
+4,943
+14% +$555K 0.01% 863
2015
Q3
$3.3M Buy
34,213
+13,970
+69% +$1.35M ﹤0.01% 938
2015
Q2
$2.07M Buy
+20,243
New +$2.07M ﹤0.01% 1020